CSF3 and infection: A number of meta-analytic studies of randomized controlled trials have reported that the use of G-CSF for primary prophylaxis is associated with a shorter duration of neutropenia, shorter hospitalization, reduced risk of FN, and lower mortality rate due to infection [3, 4, 21].